The second genome: Effects of the mitochondrial genome on cancer progression

Chapter

Abstract

  • © 2019 Elsevier Inc. The role of genetics in cancer has been recognized for centuries, but most studies elucidating genetic contributions to cancer have understandably focused on the nuclear genome. Mitochondrial contributions to cancer pathogenesis have been documented for decades, but how mitochondrial DNA (mtDNA) influences cancer progression and metastasis remains poorly understood. This lack of understanding stems from difficulty isolating the nuclear and mitochondrial genomes as experimental variables, which is critical for investigating direct mtDNA contributions to disease given extensive crosstalk exists between both genomes. Several in vitro and in vivo models have isolated mtDNA as an independent variable from the nuclear genome. This review compares and contrasts different models, their advantages and disadvantages for studying mtDNA contributions to cancer, focusing on the mitochondrial-nuclear exchange (MNX) mouse model and findings regarding tumor progression, metastasis, and other complex cancer-related phenotypes.
  • Digital Object Identifier (doi)

    International Standard Book Number (isbn) 13

  • 9780128171530
  • Pubmed Id

  • 1415418
  • Start Page

  • 63
  • End Page

  • 105
  • Volume

  • 142